EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria

Christina Gjerlev Poulsen iD, Daniel G K Rasmussen, Federica Genovese, Tine W Hansen, Signe Holm Nielsen, Henrik Reinhard, Bernt Johan von Scholten, Peter K Jacobsen, Hans-Henrik Parving, Morten Asser Karsdal, Peter Rossing iD, Marie Frimodt-Møller

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0283296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Christina Gjerlev Poulsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Copenhagen, Herlev, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danmarks Grundforskningsfond, Innovationsfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic kidney disease is a major cause of morbidity and mortality. Dysregulated turnover of collagen type III is associated with development of kidney fibrosis. We investigated whether a degradation product of collagen type III (C3M) was a risk marker for progression of chronic kidney disease (CKD), occurrence of cardiovascular disease (CVD), and mortality during follow up in people with type 2 diabetes (T2D) and microalbuminuria. Moreover, we investigated whether C3M was correlated with markers of inflammation and endothelial dysfunction at baseline.

Methods

C3M was measured in serum (sC3M) and urine (uC3M) in 200 participants with T2D and microalbuminuria included in an observational, prospective study at Steno Diabetes Center Copenhagen in Denmark from 2007–2008. Baseline measurements included 12 markers of inflammation and endothelial dysfunction. The endpoints were CVD, mortality, and CKD progression (>30% decline in eGFR).

Results

Mean (SD) age was 59 (9) years, eGFR 90 (17) ml/min/1.73m 2 and median (IQR) urine albumin excretion rate 102 (39–229) mg/24-h. At baseline all markers for inflammation were positively correlated with sC3M (p≤0.034). Some, but not all, markers for endothelial dysfunction were correlated with C3M. Median follow-up ranged from 4.9 to 6.3 years. Higher sC3M was associated with CKD progression (with mortality as competing risk) with a hazard ratio (per doubling) of 2.98 (95% CI: 1.41–6.26; p = 0.004) adjusted for traditional risk factors. uC3M was not associated with CKD progression. Neither sC3M or uC3M were associated with risk of CVD or mortality.

Conclusions

Higher sC3M was a risk factor for chronic kidney disease progression and was correlated with markers of inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Renal Insufficiency, ChronicCardiovascular DiseasesHumansMiddle AgedProspective StudiesCollagen Type IIIInflammationGlomerular Filtration RateKidneyFibrosisDisease ProgressionBiomarkers

Substanzen

Collagen Type IIIBiomarkers

Autor:innen und Institutionen

  • Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Nordic Bioscience, Herlev, Denmark.
  • Novo Nordisk A/S, Søborg, Denmark.
  • Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Department of Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Christina Gjerlev Poulsen, Peter Rossing

Förderung

  • Danmarks Grundforskningsfond
  • Innovationsfonden

Zitieren

APA

Poulsen, C. G., Rasmussen, D. G. K., Genovese, F., Hansen, T. W., Nielsen, S. H., Reinhard, H., von Scholten, B. J., Jacobsen, P. K., Parving, H. H., Karsdal, M. A., Rossing, P., & Frimodt-Møller, M. (2023). Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PLOS ONE. https://doi.org/10.1371/journal.pone.0283296

Vancouver

Poulsen CG, Rasmussen DGK, Genovese F, Hansen TW, Nielsen SH, Reinhard H, et al. Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PLOS ONE. 2023. doi:10.1371/journal.pone.0283296

BibTeX
@article{Poulsen2023,
  author = {Poulsen, Christina Gjerlev and Rasmussen, Daniel G K and Genovese, Federica and Hansen, Tine W and Nielsen, Signe Holm and Reinhard, Henrik and von Scholten, Bernt Johan and Jacobsen, Peter K and Parving, Hans-Henrik and Karsdal, Morten Asser and Rossing, Peter and Frimodt-Møller, Marie},
  title = {Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0283296}
}
Kostenlos starten →